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Abstract 52 
Tribo-electrification is a common occurrence within the pharmaceutical industry where solid 53 
dosage forms constitute majority of pharmaceutical formulations. Tribo-electrification of 54 
powders leads to a range of complications such as adhesion of particulate material to the 55 
processing equipment resulting in segregation, affecting the content uniformity. Flurbiprofen, 56 
a highly charging material, was used as a model drug to investigate the tribo-electrification and 57 
adhesion characteristics by impregnating the model drug inside a mesoporous silica matrix.  58 
The model drug was impregnated using i) solvent loading, and ii) physical mixing methods, at 59 
varying degree of silica to drug ratio (5-20 % w/w). The resulting mixtures were tribo-charged 60 
using a custom built device based on a shaking concept inside a stainless steel capsule, 61 
consisting of a Faraday cup and connected to electrometer. The electrostatic charge and the 62 
percentage adhesion of Flurbiprofen were reduced in both drug loading methods. The solvent 63 
impregnation method using acetone was more successful at reducing the electrostatic charge 64 
build up on flurbiprofen than physical powder mixing. The percentage adhesion to the shaking 65 
capsule was reduced notably as a result of loading the drug in the SBA-15 porous network. The 66 
results illustrate that the incorporation of highly charged model drug inside a low-charging 67 
pharmaceutical carrier system to be an effective approach in control the induction of tribo-68 
electrification phenomena during powder processing.    69 
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1- Introduction 74 
In many industrial applications such as pharmaceutical, detergent, cosmetics and food 75 
manufacturing, powder handling is a challenging process due to complications arising during 76 
the manufacturing process. A common obstacle faced in powder handling is the powder tribo-77 
electrification phenomenon (Watanabe et al., 2007; Kaialy 2016). The phenomenon is complex 78 
and not well understood due to many factors affecting the charge transfer process. Currently, 79 
three fundamental mechanisms contributing to charge generation by tribo-electrification are 80 
most commonly reported include material transfer, ion transfer and electron transfer.  The most 81 
widely accepted theory is electron transfer, working on a principle of varying work function 82 
(∅) of material, ∅ is the minimum energy required to remove electrons in the outer electron 83 
shell of an atom. Resulting in the flow of electron from the lower work function towards the 84 
higher, inducing a potential difference across the particle surface, allowing for charge to 85 
transfer (Cross, 1987). 86 
Tribo-electrification occurs when particles come into contact with one another or the walls of 87 
processing equipment in unit operations such as mixing, conveying, granulating or blending 88 
when these two dissimilar materials make contact by impaction or shearing and are 89 
subsequently separated, holding any charge transferred (Matsusaka et al., 2010). Charged 90 
materials have a tendency to adhere or repel powder particles, resulting in flowability issues 91 
and potentially may lead to blockages of pipes by particle adhesion to the walls of processing 92 
equipment (Matsusaka and Masuda, 2003). Within the pharmaceutical industry this can be 93 
problematic and  in extreme cases, tribo-electrification of material may lead to dust explosions 94 
(Šupuk et al., 2011). These challenges are faced during common powder handling processes 95 
such as milling, filling and compaction, in addition to a rise is unit operation problems leading 96 
to segregation of materials, impacting the quality of the end product by jeopardising the content 97 
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uniformity of the batch (Lakhani and Deshpande, 2013). Investigating alternative methods for 98 
charge control is therefore crucial.  99 
SBA-15 is a highly porous material with a rising interest for its application in drug delivery 100 
(Colilla et al., 2015; Yu and Zhai, 2009). It is comprised of nano-sized cylinder filled with  101 
regular arranged pores, expected to provide a more versatile drug delivery material (Song et 102 
al., 2005). In this paper the principle of the highly charging material is embedded within the 103 
silica pores, to provide a low-charging carrier system. The model drug was impregnated using 104 
i) solvent loading, and ii) physical mixing methods, at different silica ratios and the drug 105 
loading ability was compared. The purpose of drug loading would allow for the API to be 106 
administered in its original form, without the need for lengthy steps to aid in material handling 107 
properties whilst maintaining physicochemical properties (Ghori, 2014; Ghori et al., 2015). 108 
Currently no work has been reported on the effects of SBA-15 upon the charging tendency of 109 
a pharmaceutical material, prompting the purpose of this study.  110 
As many active pharmaceutical ingredients (APIs) have a propensity to become 111 
electrostatically charged, various techniques are utilised to aid material handling by improving 112 
the physicochemical properties, however, these can lead to further complications (Šupuk et al., 113 
2013) such as extra steps  increasing processing times. For the purpose of this study, FBP) was 114 
chosen as the model material due to its crystalline nature and poor adhesion properties, factors 115 
which are characteristic of materials possessing a high propensity for tribo-charging (Šupuk et 116 
al., 2013). Murtomaa et al believe that the amorphicity has a measurable effect on the tribo-117 
charging of powders (Murtomaa et al., 2002) A study undertaken by Carter et al investigates 118 
the tribo-electrification of spray dried and crystalline lactose which concluded significant 119 
differences in charge values between the two lactose powders under the same conditions 120 
(Carter et al., 1998). A more recent studies have examined the tribo-electrification of 121 
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amorphous salbutamol sulfate which was more electropositive than jet-milled crystalline 122 
particles (Kwok and Chan, 2008). Such results could have been seen due to different surface 123 
energies between crystalline and amorphous materials leading to varying charge values (Zhang 124 
et al., 2006). FBP is well known for its poor compaction, solubility and dissolution (Ghori et 125 
al., 2014a; Rudrangi et al., 2016) properties due to its propensity to adhere to the punch 126 
surfaces, FBP has been reported as a highly sticking compound (Paul et al., 2017). The 127 
adhesion properties may be due to the ability of the powder to withhold high levels of 128 
electrostatic charge, reducing the propensity for gaining charge may lead to an improvement 129 
in material handling as well as compaction properties (Šupuk et al., 2013). In this study we 130 
have incorporated FBP within the extremely porous SBA-15 material, which possesses a large 131 
surface area, allowing for the pores to be filled with the drug, with an aim reduce the charge 132 
propensity whilst maintaining therapeutic potency, as well as quantifying the percentage 133 
adhesion of drug material to the shaker walls. The model would then be used to explore other 134 
systems to investigate their charging tendency as a result of being loaded within the low-135 
charging carrier system.  136 
 137 
 138 
 139 
 140 
 141 
 142 
 143 
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2- Materials and Methods 144 
2.1- Materials 145 
Flurbiprofen was purchased from Aesica Pharmaceutical Ltd. (Cramlington, UK) and 146 
Mesoporous silica (SBA-15) was obtained from ACS Material (California, USA). The solvent 147 
used was Acetone, purchased from Fisher Scientific (Loughborough, UK).  148 
2.2- Methods 149 
2.2.1- Fractionation of SBA-15 and FBP particle size 150 
Particle size fractions of SBA-15 (150–250 μm) and Flurbiprofen (38–63 μm) were obtained 151 
through mechanical sieving. All the powders were stored at ambient temperature (18–24 °C) 152 
and humidity (RH 36%–44%) before any further investigations. 153 
2.2.1- Development of SBA-15: FBP powder mixtures 154 
The binary mixtures of SBA-15 and FBP of varying SBA-15 to FBP ratios (5-20 %w/w) were 155 
prepared using two loading methods; solvent impregnation and powder impregnation, allowing 156 
for a comparison of drug distribution throughout the mesoporous silica matrix.  157 
2.2.1.1- Solvent impregnation method 158 
SBA-15: FBP mixtures were prepared by dissolving 1.5g of pure drug in 5 ml of acetone. After 159 
the drug has completely dissolved, the ratio dependant quantity of SBA-15 was added, and the 160 
solution was stirred for 5 min. The samples were initially dried at room temperature for 24 h 161 
followed by a further 24 h drying at 40 °C using conventional oven. 162 
 163 
 164 
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2.2.1.2- Powder physical mixing 165 
SBA-15: FBP physical mixtures were prepared by placing 5g of drug and the relevant ratio of 166 
SBA-15 in a glass container and mixed for 10 minutes at 49 rpm using a Turbula mixer (Glen 167 
Creston Ltd, UK). The container was left for 2 days for any potential charge to dissipate. 168 
2.2.2- Physicochemical characterisation of powder mixtures  169 
2.2.2.1- Differential Scanning Calorimetry (DSC) studies  170 
Differential Scanning Calorimetry (DSC) was undertaken using Mettler Toledo SC 821, 171 
Mettler-Toledo Ltd., Leicester, UK. Specimens of 5-10 mg were placed in vented aluminium 172 
pans under nitrogen purge at 50 ml min-1, over a range of 25-300°C at a heating rate of 10°C 173 
min-1. An estimated percent crystallinity of the binary mixtures was assessed using Eq. 1, 174 
relative to the melting enthalpy of crystalline FBP as a reference.  175 
% 𝑅𝑒𝑙𝑎𝑡𝑖𝑣𝑒 𝑐𝑟𝑦𝑠𝑡𝑎𝑙𝑙𝑖𝑛𝑖𝑡𝑦 = (
𝑚𝑒𝑙𝑡𝑖𝑛𝑔 𝑒𝑛𝑡ℎ𝑎𝑙𝑝𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑠𝑎𝑚𝑝𝑙𝑒
𝑚𝑒𝑙𝑡𝑖𝑛𝑔 𝑒𝑛𝑡ℎ𝑎𝑙𝑝𝑦 𝑜𝑓 𝑡ℎ𝑒 𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑠𝑡𝑎𝑛𝑑𝑎𝑟𝑑
)  𝑋 100                  Eq. 1 176 
2.2.2.2- Thermogravimetric analysis (TGA) 177 
Thermogravimetric analysis (TGA) was performed using a Mettler Toledo TGA, Mettler-178 
Toledo Ltd., Leicester, UK, samples between 5-10 mg and a temperature range of 25-500°C 179 
at a heating rate of 5°C min-1 were used.  The process was carried out under a nitrogen purge 180 
at a constant flow rate of 50 ml min-1. 181 
2.2.2.3- Powder X-Ray diffraction (XRD)  182 
The Bruker D2 Phaser XRD diffractometer by Bruker, Coverntry, UK was used to obtain 183 
patterns for the parent drug (FBP) and SBA-15 as well as the powder mixes. The sample 184 
powders were scanned at a 2 θ (5° -100°) at a scanning rate of 1.5 min-1. 185 
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2.2.2.4- Content uniformity analysis 186 
The concentration of FBP was quantified by UV-Vis spectrophotometry, (Jenway 6305 UV-187 
Vis Spectrophotometer, λ max = 247 nm) (Verma et al., 2016) where 10 mg of sample was 188 
randomly obtained from each batch (n=3), dissolved in 100 ml of phosphate buffer at pH 7.2 189 
for 24 hours (Ghori et al., 2014b). The sample was then filtered using a 0.45ml PTFE syringe 190 
filter. The acceptance limit was in the 95-105 % range (BP 2012).   191 
2.2.3.5- Brunauer–Emmett–Teller (BET) analysis 192 
Pore size and surface area was analysed using the Micromeritics 2020 apparatus. The study 193 
was carried out at 77 K, prior to analysis the samples were de-gassed in a vacuum oven at 194 
100°C for 10 hours, using a FlowPrep 060. The surface area of the sample was calculated using 195 
Brunauer–Emmett–Teller (BET) equation from the adsorption data (Brunauer et al., 1938). The 196 
pore-size distribution results are generated from the adsorption branches of the nitrogen 197 
isotherms using the BJH model (Barrett et al., 1951). Each sample was analysed in duplicate.  198 
2.2.3- Tribo-electrification studies  199 
The charge to mass ratio (Q/M) of the materials was obtained using a shaking concept originally 200 
described by (Šupuk et al., 2009) and adopted in various studies (Asare-Addo et al., 2013; 201 
Ghori et al., 2014; Ghori 2014; Ghori et al., 2015 ). Briefly, Powder (~0.1 g) was placed inside 202 
a stainless steel cylindrical container (10 mL) and shaken in a horizontal direction (Retsch MM 203 
400) for 0.5, 2, 5 and 10 min at a vibration frequency of 20 Hz. The charged powder particles 204 
were then poured into a Faraday cup, connected to an electrometer (Keithley Model 6514). A 205 
Faraday cup comprises two concentric cups made up of a conducting material. The outer cup 206 
is slightly larger and acts as an electrical shield and a lid covers it. Both are very important to 207 
prevent the effect of any extraneous electric fields. The inner cup is directly attached to an 208 
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electrometer for charge measurement and can be removed to measure the weight of the sample 209 
poured. The two cups are separated by a PTFE insulator. As charged samples are loaded into 210 
the inner Faraday cup, this induces an equal but opposite charge on the wall of inner faraday 211 
cup, providing the net charge on the object. The resolution of the charge measurement was in 212 
nano-Coulombs (nC). The charge to mass ratio (Q/M) was calculated by dividing the final 213 
charge with the final mass of the respective powder. Each tribo-electric charging test was 214 
repeated three times and the shaking container was cleaned between each test by washing with 215 
isopropyl alcohol, rinsing with water and drying with compressed air to remove any residual 216 
deposits, impurities and surface charges. All the powder samples were stored overnight at an 217 
ambient temperature (21–23.1 °C) and humidity (RH 36%–48%) for dissipation of tribo-218 
charging. Studies were carried out at an ambient temperature (18–24 °C) and humidity (RH 219 
36%–44%). Maximum charge was gained after 5 min shaking for FBP and SBA-FBP powder 220 
mixtures. Maximum charge acquisition data (Qmax) are presented as charge to mass ratio (Q/M) 221 
at the end of each tribo-electrification experiment (n = 3). 222 
2.2.4- Powder surface adhesion studies 223 
Powder particle adherence to the surface of the stainless steel container used in the tribo-224 
electrification studies was calculated from mass difference by deducting the final amount 225 
recovered (post-shaking and tapping) from the initial amount of sample loaded into the shaking 226 
vessel and powder mass loss was demonstrated as a percentage (%) of powder adhesion (Ghori 227 
2014; Ghori et al., 2014; Ghori et al., 2015). 228 
 229 
3- Results and discussion 230 
3.1- Thermal Analysis  231 
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Thermal analysis was carried out using DSC and TGA. In the DSC traces obtained for SBA-232 
15, the melting peak was not observed in the (Figure 1) temperature range tested (25 – 350°C) 233 
due to its high melting point of >1600°C. Table 1 illustrates the melting point and % relative 234 
crystallinity for all samples for both methods. The melting point corresponding to the parent 235 
drug is a sharp endothermic melting peak at ~116°C. However, melting endotherms for the 236 
binary mixtures showed reduced intensity as the percentage of SBA increased for both loading 237 
methods, this may be due to the crystalline material   entering the pore matrix of the SBA-15, 238 
so a reduced amount of material is available, also   SBA-15 did not present a melting enthalpy 239 
within the chosen temperature range, resulting in a reduction in intensity of the melting 240 
endotherm formed by the binary powder mixtures. From the DSC (Figure 1 and Table 1), data 241 
it is evident that the introduction of SBA-15 has no chemical influence upon FBP as such 242 
changes would influence the tribo-electrification results, strongly indicating that the 243 
suppression of charge propensity is due to the drug loading within the pore network of the 244 
mesoporous silica. The enthalpy of FBP was 116.5 J/g-1 in contrast to 20% SBA by physical 245 
mixing at 71.5 J/g-1, signifying a decrease in crystallinity as a result of loading the FBP within 246 
the pores of the SBA-15. The results show approximately 40-50% reduction in crystallinity at 247 
the highest silica loading concentration in contrast to the pure drug material, with solvent 248 
impregnation showing a greater reduction in crystallinity for all SBA-15: FBP mixtures.  249 
Thermogravimetric analysis was undertaken in order to determine successful uptake of FBP 250 
onto SBA-15 and results are depicted in Figure 2. The total weight loss of 97.5% was observed 251 
for FBP (Figure 2) at 270°C. The drug loading fraction can be estimated from the ratio of the 252 
weight loss occurring between 100 and 500°C from the initial weight, considering the 253 
limitation of distinguishing any drug sample on the surface of SBA-15 from drug material 254 
loaded within the pores. For samples prepared by both methods, the weight loss remained 255 
constant initially and the loss initiated at approximately 175-200°C, beyond this point the mass 256 
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decreased rather significantly; reaching a state of maximum degradation, in the case of FBP 257 
the weight loss was ~97% in comparison the drug loaded within SBA-15, as little as 5% of the 258 
silica showed a ~65% reduction in weight for solvent impregnation and ~55% for the physical 259 
mixture, indicating successful drug loading of the drug material within the pores rather than 260 
coating the surface of the mesoporous silica . As the SBA percentage increase the percentage 261 
weight loss decreased, where 20% SBA-15 showed a reduction by ~65% in comparison to FBP 262 
at 97% (Figure 2). Both loading methods presented a similar pattern to the pure FBP. TGA 263 
analysis showed no weight loss that would be indicative of hydrate/solvate formation, which 264 
may have occurred during the solvent impregnation method, the formation of a hydrate/solvate 265 
may influence tribo-electrification of a material.  266 
3.2- Powder X-ray diffraction 267 
XRD was used to confirm sample crystallinity for the FBP, SBA-15, and the binary mixtures 268 
of FBP and SBA-15 prepared by solvent impregnation as well as physical impregnation. The 269 
crystallinity is an important factor having a substantial role when considering the properties of 270 
a material, including tribo-electrification. The samples were analysed and differences in the x-271 
ray diffraction patterns between 5° and 100° at angle 2θ between the parent drug and their 272 
binary mixtures were compared.  As shown in Figure 3, it is evident that mesoporous silica 273 
(SBA-15) is an amorphous material. There are some variances in the peak angle between the 274 
binary mixtures of FBP and SBA-15 prepared by solvent impregnation; in comparison to pure 275 
FBP drug which possesses characteristic peaks at, 7°, 11°, 16°, and 21°. The XRD pattern of 276 
binary mixtures prepared by physical impregnation demonstrates a slight decrease in peak size, 277 
in contrast with the pure drug. The most substantial difference being observed in 20% SBA-F.   278 
3.3- Content uniformity analysis 279 
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Content uniformity of all the powder mixtures were quantified using UV-VIS spectroscopy. 280 
The percentage of drug loading was determined by dissolving the SBA-15: FBP powder 281 
mixture. The dissolved FBP was quantified by adopting the linear regression equation of the 282 
standard calibration curve of FBP.  The linearity coefficient (R2) was 0.994 and the findings 283 
showed all the binary powder mixtures contained 95-105% of FBP theoretical content, hence 284 
satisfying the criteria of British Pharmacopeia (BP 2012). 285 
3.4- Pore size distribution and specific surface area measurement 286 
The surface area and pore size distribution of SBA-15 and subsequent binary mixtures were 287 
determined by nitrogen adsorption at 77K and resulted are summarised in Table 2. The specific 288 
surface area of pure SBA-15 sample was found to be 744.6 m2/g-1 and significantly decreased 289 
to 6.4 m2/g-1 and 11.9 m2/g-1 in the case of the binary mixtures with FBP and SBA-15 prepared 290 
by solvent impregnation and physical impregnation respectively, at 5% SBA-15: FBP 291 
concentration. The data for 10% SBA-15 concentration showed a slight increase for both 292 
physical impregnation and solvent impregnation at 30.2 m2/g-1 and 13.7 m2/g-1 respectively in 293 
comparison to 5%. Results obtained for 15% SBA-15 display a specific surface area of 45.6 294 
m2/g-1 for physical impregnation and 25.9 m2/g-1 for solvent impregnation. In comparison to 295 
20% mesoporous silica which showed 58.2 m2/g-1 and 23.4 m2/g-1 for physical impregnation 296 
and solvent impregnation respectively. This data represents successful loading of FBP within 297 
the pores of the SBA-15, however, the degree of drug loading within the SBA-15 pore network 298 
was greater for the solvent impregnation technique in comparison to the physical impregnation 299 
method. Confirmation of successful drug loading is imperative as it indicated that drug loading 300 
technique does play a role, in the degree of drug uptake as well as tribo-charging of the material. 301 
The greater the drug loading within the pores results in a reduced amount of drug material 302 
available to charge. The pore volume data was obtained using Barrett-Joyner-Halenda (BJH) 303 
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analysis. The method utilises a modified kelvin equation which accounts for the quantity of 304 
adsorbate removed from the pores as there is a decrease in relative pressure from high to low. 305 
This in turn relates to the volume of pore data obtained.  The mesoporous silica (SBA-15) had 306 
a mesoporous volume of 0.79 cm3 g-1 whilst the pore volume of binary mixtures was found to 307 
be 0.1 cm3 g-1 and below depending on the SBA -15 concentration, as well as the loading 308 
technique utilised indicating the successful inclusion of FBP within the highly porous silica. 309 
The solvent impregnation technique results in binary mixtures with a smaller surface area as 310 
well as pore volume when compared to the physical impregnation method.  311 
3.5- Tribo-electrification and powder surface adhesion studies  312 
The charge of the samples was measured at time intervals of 0.5, 2, 5 and 10 minutes with an 313 
initial charge recorded at time point zero which represents the charge on the sample prior being 314 
subjected to tribo-electrification. The data presented represent an average of three independent 315 
measurements obtained. The adhesion value refers to the mass loss of powder which strongly 316 
adhered to the shaking container (Figures S1-S2). The electrostatic charge level of the model 317 
drug increased with shaking time where a maximum electronegative charge of -226 nC g−1 318 
(Figure 4) reached after 5 minutes of shaking. This indicates the movement of electrons from 319 
walls of the shaker to the drug particles which might be due to the higher work function of the 320 
FBP, resulting in a gain of electrons.  321 
The triboelectric charge of SBA-15 was also measured and obtained at the time intervals 322 
mentioned above. SBA-15 has an extremely low charging tendency as a small charge to mass 323 
ratio was produced.  The sample charged negatively against the stainless steel shaker at each 324 
time interval, with a reduction in charge level with shaking time towards electropositive until 325 
a charge level of -1.2 nC g−1 was reached after 10 mins (Figure 4).  326 
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The SBA-15 produced a negative charge due to the transfer of electrons from the wall of the 327 
shaker to the powder particles as a result of the walls of the capsule possessing a lower work 328 
function. When comparing the adhesion data of the SBA-15 (Figure S1) to the model drug 329 
(Figure S2) it is evident that there is a vast reduction in tendency of the powder to adhere to 330 
the walls, FBP shows approximately 45% adhesion when induced to the shaking motion for 5 331 
minutes in comparison to SBA-15 which had a maximum adhesion of approximately 18% after 332 
10 minutes. The adhesion of the material to the shaker walls occurs due to the formation of an 333 
electric field, affecting the potential difference and resulting in greater adhesion. All mixtures 334 
were subjected to tribo-charging for 5 minutes, the charge results of the binary mixture 335 
produced by solvent impregnation method show that the highest charging sample was 5% SBA-336 
F (Figure 5), the charging ranged from approximately -2.0 to -10 nC/g in comparison to FBP 337 
(-226 nC/g), Figure 4. It is evident from the data produced that the charging and adhesion is 338 
vastly affected by the ratio of the two samples in the mix. As the ratio of SBA-15 increased 339 
from 5% to 20% the charge level reduced, also from the adhesion data (Figure 6) it is apparent 340 
that the sticking propensity has reduced to below 14% for all ratios chosen for solvent 341 
impregnation in comparison to FBP at approximately 45%. There is an obvious reduction when 342 
as little as 5% of SBA is used. This reduction in charge and adhesion could be due to the change 343 
in particle-particle interactions between the FBP particles, due to the drug incorporating within 344 
the pores of the SBA-15, which acts as a low-charging carrier system, as drug only results in 345 
FBP particles induced to lateral motion upon other drug particles. As the concentration of SBA-346 
15 has increased the probability of drug entering the pores increases, reducing the quantity of 347 
the highly charging and sticking drug available to be induced to tribo-electrification with the 348 
shaking container walls, the remainder drug material is induced to drug-SBA-15 interactions 349 
reducing the probability of drug-drug interactions. All samples charged negatively against the 350 
stainless steel container due to having a higher work function than the capsule and accepting 351 
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the charge transfer in accordance to the electron transfer theory. The charge and percentage 352 
adhesion data obtained for the physical impregnation sample was also investigated at a time 353 
interval of 5 minutes. From Figure 5 it is apparent that the charge of the powder mix decreased 354 
however not as significantly as when preparing by solvent impregnation. This may be due to a 355 
reduced chance of FBP loading within the pores as any agglomerates would be too large to 356 
enter the pores, which is evident from the BET data showing a larger surface area available 357 
after drug loading had occurred in comparison to the solvent impregnation method. The 358 
charging decreased as the percentage of SBA-15 increased form 5% to 20%. Like the solvent 359 
impregnation method, the physical impregnation did  reduce the percentage adhesion (Figure 360 
6) of particles to the capsule walls and charging propensity of material, this was apparent when 361 
as little as 5% SBA-15 was used, resulting in better material handling properties. 362 
 363 
4- Conclusions  364 
The study confirms that the drug loading method and quantity of SBA-15 as the non-charging 365 
carrier system proposed in this work have an effect on the tribo-charging propensity and 366 
adhesion behaviour of FBP. It is commonly known that FBP has a tendency to charge 367 
significantly, hence used as a model drug within this study. FBP produced a saturated charge 368 
level of -226.4 nC/g and surface adhesion of 45%. With potential complications arising during 369 
powder handling, such as flowability of the material and poorer content uniformity. Changes 370 
to the particle to particle as well as particle to wall interactions have shown to modify the 371 
electrostatic properties of FBP due to its inclusion within the non-charging carrier SBA-15 372 
system, which was demonstrated by the results as the SBA-15 concentration increased, the 373 
charging tendency and adhesion tendency of the material reduced drastically in comparison to 374 
FBP on its own. The drug loading method utilised did not vastly affect the results, as both 375 
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loading techniques reduced the net charge and percentage adhesion significantly in comparison 376 
to the parent drug. The solvent impregnation method saw a greater reduction in charge when 377 
compared to physical impregnation, this is potentially due to a greater quantity of FBP entering 378 
the pores in comparison to physical impregnation whereby any agglomerates are too large to 379 
enter, would stick to the surface of the SBA-15 particles and play a role in increasing the 380 
probability of drug to drug interactions 381 
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 471 
Figure 1, DSC profiles of pure SBA-15, FBP and their respective powder mixture prepared by (a) physical mixing and (b) solvent 472 
impregnation.  473 
 474 
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 483 
Figure 2, TGA profiles of pure SBA-15, FBP and their respective powder mixture prepared by (a) physical mixing and (b) solvent 484 
impregnation.  485 
 486 
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 495 
 496 
Figure 3, XRD profiles of pure SBA-15, FBP and their respective powder mixture prepared by (a) physical mixing and (b) solvent 497 
impregnation. 498 
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Figure 4, Tribo-electric charging profiles of pure SBA-15 and FBP with respect to shaking time 508 
 509 
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 519 
Figure 5, Charge to mass ratio as a function of shaking time inside a stainless steel container at 20 Hz and a temperature of 22 °C with 520 
the relative humidity at 37.5% for SBA-FBP mixture produced by physical mixing and  solvent impregnation. 521 
 522 
25 
 
 523 
 524 
 525 
 526 
 527 
 528 
 529 
 530 
 531 
Figure 6, The particle adhesion to stainless steel container walls after shaking at 20 Hz at 22.4°C and relative humidity 37.5% of the 532 
binary mixtures of FBP and SBA-15 that were prepared by physical mixing and solvent impregnation. 533 
 534 
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 535 
Table1, Summary of DSC melting parameters and relative crystallinity (%) of FBP and its powder mixtures 536 
 537 
 538 
 539 
 540 
 541 
 542 
 543 
 544 
 545 
Sample Melting peak (°C) Melting enthalpy (Jg-1) Relative crystallinity (%) 
Flurbiprofen 116.6 -116.5 100 
5% SBA (PM)  116.67 -107.9 92.61 
10% SBA (PM) 116.44 -102.22 87.74 
15% SBA (PM) 116.79 -84.74 72.73 
20% SBA (PM) 116.42 -71.48 61.35 
5% SBA (SI) 119.21 -101.58 87.19 
10% SBA (SI) 117.15 -89.75 77.03 
15% SBA (SI) 117.54 -67.86 58.24 
20% SBA (SI) 118.16 -61.23 52.55 
SI = solvent impregnation, PM = Powder mixtures    
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Table 2, Average pore diameter, specific surface area, and pore volume (pore sizes from17.000 Å to 3000.000 Å) for SBA-15 and the binary 546 
mixtures of FBP and SBA-15 prepared by solvent impregnation and physical mixing. 547 
 548 
 549 
 550 
 551 
 
 Pure Compounds Physical Mixing Solvent Impregnation 
SBA FBP 5%  
SBA-F 
10%  
SBA-F 
15%  
SBA-F 
20%  
SBA-F 
5%  
SBA-F 
10%  
SBA-F 
15%  
SBA-F 
20%  
SBA-F 
BET Surface Area/ m2 g-1 
 
744.6 - 11.9 30.3 45.6 58.2 6.4 13.7 25.9 23.4 
BJH Adsorption cumulative surface 
area of pores between 17.000 Å to 
3000.000 Å /  m2 g-11 
520.9 - 11.3 34.7 53.3 68.8 5.9 14.4 28.7 26.7 
BJH Desorption cumulative 
surface area of pore  between 
17.000 Å to  3000.000 Å /  m2 g-1 
595.5 - 14.5 40.1 3.1 77.5 7.2 16.8 33.5 30.4 
BJH Adsorption cumulative pore 
volume between 17.000 Å to 3000.000 
Å / cm3 g-1 
0.79 - 0.02 0.05 0.08 0.10 0.02 0.03 0.05 0.05 
BJH Desorption cumulative pore 
volume between 17.000 Å to 3000.000 
Å / cm3 g 
0.82 - 0.4 0.5 0.5 0.5 0.5 0.3 0.3 0.2 
Adsorption average pore width (4V/A 
by BET) / Å 
44.1 - 61.8 62.7 64.5 64.3 57.0 62.4 62.6 67.5 
BJH Adsorption average pore width 
(4V/A) / Å 
60.5 - 71.2 62.1 61.9 59.9 80.7 72.8 66.5 70.7 
BJH Desorption average pore width 
(4V/A) / Å 
55.1 - 55.5 53.6 53.9 53.3 65.7 62.1 59.1 62.0 
